# Jovem Cientista BRCA Real Evidence Quick Pass - Publication Readiness

- Generated at: 2026-05-11T05:09:16Z
- Overall readiness: 95%
- Overall status: ready
- Claim tier: strong (98%)
- External robustness: 75%
- Real-data freeze: 100%
- Ready for high-impact submission: not yet
- Cohorts: 5 total / 4 external

## Executive Summary

- Strong areas: Cohort design and labels, Data versioning and manifests, Public source traceability, Cohort independence, Real-data cohort freeze, Internal validation package, External validation coverage, Comparative evidence strength, Claim strength and framing, Artifact package completeness
- Critical gaps: none.
- Best external signal: clinvar_expert_external_validation_brca1 -> gene_balanced_specialist (AUC-ROC=0.9223, delta=0.1704, evidence=supported_gain)

## Criteria

### Cohort design and labels

- Score: 100%
- Status: ready
- Critical: yes
- Evidence: 1 cohort(s) de treino, 4 coorte(s) externas e 100% das coortes com pelo menos duas classes.
- Next step: Garantir exatamente uma coorte de treino e ampliar coortes externas rotuladas quando necessario.

### Data versioning and manifests

- Score: 100%
- Status: ready
- Critical: yes
- Evidence: 100% das coortes com data release manifest e 100% com fingerprint do dataset integrado.
- Next step: Assegurar manifests e fingerprints para todas as coortes usadas no estudo.

### Public source traceability

- Score: 96%
- Status: ready
- Critical: yes
- Evidence: Media de release=92%, schema=100% e catalog readiness=96%.
- Next step: Completar tracking de release e cobertura estrutural das fontes publicas reais por coorte.

### Cohort independence

- Score: 100%
- Status: ready
- Critical: yes
- Evidence: Independencia global em 100% com max overlap treino/externo=0%.
- Next step: Eliminar sobreposicao de variantes entre treino e validacao externa antes da submissao final.

### Real-data cohort freeze

- Score: 100%
- Status: ready
- Critical: yes
- Evidence: Freeze de coortes em 100% com 0 coorte(s) ainda bloqueadas por demo/example.
- Next step: Substituir datasets de exemplo por coortes reais versionadas antes da submissao final.

### Internal validation package

- Score: 100%
- Status: ready
- Critical: no
- Evidence: Training metrics=100%, repeated holdout=100%, gene-stratified metrics=100% e model registry=100%.
- Next step: Manter repeated holdout, modelos versionados e analise gene-estratificada em toda release.

### External validation coverage

- Score: 100%
- Status: ready
- Critical: yes
- Evidence: 100% das coortes externas com metrica combinada e 100% com comparacao pareada AUC-ROC.
- Next step: Executar validacao externa para todas as coortes planejadas e preservar comparacoes pareadas.

### Comparative evidence strength

- Score: 85%
- Status: ready
- Critical: yes
- Evidence: 75% das coortes com ganho suportado, 75% com ganho positivo e melhor experimento gene_balanced_specialist.
- Next step: Rodar o benchmark em dados reais e buscar ganho consistente contra o baseline declarado.

### External robustness

- Score: 75%
- Status: partial
- Critical: yes
- Evidence: Robustez externa em 75%, sign confidence=100% e clinical robustness=93%.
- Next step: Consolidar wins de calibracao, seguranca e estabilidade cross-cohort antes de ampliar a alegacao translacional.

### Claim strength and framing

- Score: 98%
- Status: ready
- Critical: yes
- Evidence: Claim tier strong em 98% para hybrid_plus_external__logistic_regression vs external_predictors_only__logistic_regression.
- Next step: Fortalecer a alegacao central do estudo ate um tier moderado ou forte antes da submissao.

### Artifact package completeness

- Score: 100%
- Status: ready
- Critical: yes
- Evidence: 100% dos artefatos centrais do estudo foram materializados no output final.
- Next step: Garantir que tabelas, dossie e manifestos sejam exportados em toda execucao de estudo.

## Cohort Evidence

- public_brca_training (train): n=869, release=92%, schema=100%, benchmark=48%.
- clinvar_expert_external_validation_brca1 (external_test): n=204, release=92%, schema=100%, benchmark=48%.
- clinvar_expert_external_validation_brca2 (external_test): n=175, release=92%, schema=100%, benchmark=48%.
- bridges_like_external_validation_brca1 (external_test): n=168, release=92%, schema=100%, benchmark=48%.
- bridges_like_external_validation_brca2 (external_test): n=289, release=92%, schema=100%, benchmark=48%.

## External Comparative Evidence

- clinvar_expert_external_validation_brca1: best=gene_balanced_specialist (AUC-ROC=0.9223) | delta vs baseline=0.1704 [0.0918, 0.2292] => supported_gain
- clinvar_expert_external_validation_brca2: best=biochemical_only__logistic_regression (AUC-ROC=0.7764) | delta vs baseline=0.1376 [0.0491, 0.2421] => supported_gain
- bridges_like_external_validation_brca1: best=external_predictors_only__logistic_regression (AUC-ROC=0.5904) | delta vs baseline=-0.0071 [-0.1444, 0.1359] => no_gain
- bridges_like_external_validation_brca2: best=hybrid__logistic_regression (AUC-ROC=0.7509) | delta vs baseline=0.5175 [0.3516, 0.7461] => supported_gain

## Recommended Next Actions

- Consolidar wins de calibracao, seguranca e estabilidade cross-cohort antes de ampliar a alegacao translacional.